Associated Papers
Modeling the novel SERD elacestrant in cultured fulvestrant-refractory HR-positive breast circulating tumor cells.
Dubash TD et al.
Breast Cancer Research and Treatment, 2023
37318638 (PubMed )
Supplement: 10549_2023_6998_MOESM1_ESM.pdf
A Gene Panel Associated With Abemaciclib Utility in ESR1-Mutated Breast Cancer After Prior Cyclin-Dependent Kinase 4/6-Inhibitor Progression.
Brett JO et al.
Jco Precision Oncology, 2023
Genetic Testing to Inform Epilepsy Treatment Management From an International Study of Clinical Practice.
McKnight D et al.
Jama Neurology, 2022
36315135 (PubMed )
Supplement: jamaneurol-e223651-s001.pdf
Phenotypic Spectrum and Molecular Findings in 17 ATR-X Syndrome Italian Patients: Some New Insights.
Vaisfeld A et al.
Genes, 2022
The chromatin remodeller ATRX facilitates diverse nuclear processes, in a stochastic manner, in both heterochromatin and euchromatin.
Truch J et al.
Nature Communications, 2022
35710802 (PubMed )
Supplement: 41467_2022_31194_MOESM1_ESM.pdf
Mutations in the chromatin-associated protein ATRX.
Gibbons RJ et al.
Human Mutation, 2008
A new detection method for ATRX gene mutations using a mismatch-specific endonuclease.
Wada T et al.
American Journal of Medical Genetics. Part A, 2006
Mutations in PHD-like domain of the ATRX gene correlate with severe psychomotor impairment and severe urogenital abnormalities in patients with ATRX syndrome.
Badens C et al.
Clinical Genetics, 2006
Molecular-clinical spectrum of the ATR-X syndrome.
Gibbons RJ et al.
American Journal of Medical Genetics, 2000
Select a paper to view details